// App-Quantinova.ai

: CSF and PET biomarkers for noradrenergic dysfunction in neurodegenerative disease: a systematic review and meta-analysis.

Researchers

Presenter

  • Elisa Lancini

Principal Investigators

  • Franziska Bartl

  • Lena Haag

  • Maren Rühling

  • Nicholas J. Ashton

  • Henrik Zetterberg

  • Emrah Duzel

  • Dorothea Hämmerer

  • Matthew Betts

Medical Centers

  • Institute of Psychiatry, Psychology & Neuroscience, King's College London

  • University Hospital Regensburg

  • King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • The Wellcome Trust Centre for Neuroimaging, University College London

  • Institute for Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Institute of Cognitive Neuroscience, University College, London, United Kingdom

  • Otto-von-Guericke University

  • German Center for Neurodegenarative Diseases (DZNE)

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • UK Dementia Research Institute

  • Institute of Physiology and Neuroscience, University of Gothenburg

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Center for Behavioral Brain Science (CBBS)

  • NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation

Locations

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • 3-Methoxy-4-hydroxyphenylglycol

  • Cerebrospinal fluid

Drug/Treatment

  • Norepinephrine topical

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A